Capital World Investors Ab Cellera Biologics Inc. Transaction History

Capital World Investors

$586 Billion
Q1 2024

A detailed history of Capital World Investors transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Capital World Investors holds 8,351,293 shares of ABCL stock, worth $32.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,351,293

Previous 8,351,293 -0.0%

Holding current value

$32.7 Million

Previous $47.7 Million 20.66%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$3.91 - $5.93 $270,572 - $410,356	-69,200 Reduced 0.82%	8,351,293 $47.7 Million
Q2 2023 Aug 11, 2023	SELL	$5.66 - $7.59 $5.13 Million - $6.88 Million	-907,000 Reduced 9.72%	8,420,493 $54.4 Million
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $2.4 Million - $3.68 Million	-253,266 Reduced 2.64%	9,327,493 $94.5 Million
Q3 2022 Nov 14, 2022	SELL	$9.2 - $13.68 $31.8 Million - $47.3 Million	-3,457,598 Reduced 26.52%	9,580,759 $94.8 Million
Q2 2022 Aug 15, 2022	SELL	$5.72 - $10.65 $29.9 Million - $55.7 Million	-5,229,418 Reduced 28.63%	13,038,357 $139 Million

Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $28.2 Million - $53.5 Million	-3,783,928 Reduced 17.16%	18,267,775 $178 Million
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $29 Million - $39.5 Million	2,230,296 Added 11.25%	22,051,703 $315 Million
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $95.1 Million - $137 Million	6,405,970 Added 47.75%	19,821,407 $397 Million
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $187 Million - $316 Million	9,254,567 Added 222.42%	13,415,437 $295 Million
Q1 2021 May 14, 2021	BUY	$23.29 - $53.2 $12.1 Million - $27.7 Million	521,447 Added 14.33%	4,160,870 $141 Million
Q4 2020 Feb 12, 2021	BUY	$39.0 - $58.9 $142 Million - $214 Million	3,639,423 New	3,639,423 $146 Million

Others Institutions Holding ABCL

# of Institutions

171

Shares Held

120M

Call Options Held

264K

Put Options Held

254K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $1.12B
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Ab Cellera Biologics Inc. Transaction History